Effects of the enantiomers of (±)-HA-966 on dopamine neurons: an electrophysiological study of a chiral molecule

European Journal of Pharmacology

Volumn 285, Issue 1, 1995, Pages 79-88

  Shepard, Paul D ^a   Connelly, Stephen T ^a   Lehmann, Heike ^a   Grobaski, Kenneth C ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Dopamine; GABA ( aminobutyric acid); NMDA (N methyl d aspartate); Pyrrolidinone; Substantia nigra

Indexed keywords

3 AMINO 1 HYDROXY 2 PYRROLIDINONE; 3 AMINOPROPYL(DIETHOXYMETHYL)PHOSPHINIC ACID; 4 AMINOBUTYRIC ACID B RECEPTOR; 4 AMINOBUTYRIC ACID B RECEPTOR BLOCKING AGENT; 2 PYRROLIDONE DERIVATIVE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; ORGANOPHOSPHORUS COMPOUND; RECEPTORS, GABA B; RECEPTORS, N METHYL D ASPARTATE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; DRUG ANTAGONISM; ELECTROPHYSIOLOGY; ENANTIOMER; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SINGLE UNIT ACTIVITY; STEREOSPECIFICITY; SUBSTANTIA NIGRA; ANIMAL; DOSE RESPONSE; DRUG EFFECT; PHYSIOLOGY; RAT STRAIN; STEREOISOMERISM;

ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; ORGANOPHOSPHORUS COMPOUNDS; PYRROLIDINONES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GABA-B; RECEPTORS, N-METHYL-D-ASPARTATE; STEREOISOMERISM; SUBSTANTIA NIGRA; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0028982539     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(95)00390-7     Document Type: Article

References (60)

1. Anxiolytic-like effects of N-methyl-d-aspartate-associated glycine receptor ligands in the rat potentiated startle test
2. 1-Hydroxy-3-amino-pyrrolidone-2 (HA-966). II. Extrapyramidal aspects
3. 1-Hydroxy-3-amino-pyrrolidone-2 (HA-966). I. Behavior and motor effects
4. 1-Hydroxy-3-amino-pyrrolidone-2 (HA-966)
5. Dopamine hypoactivity measured by in vivo voltammetry
6. Burst firing of mesencephalic dopamine neurons is inhibited by somatodendritic application of kynurenate
7. Tonic activation of NMDA receptors causes spontaneous burst discharge of rat midbrain dopamine neurons in vivo
8. Effects of HA-966 on conflict, social interaction, and plus maze behaviors
9. Antagonism of neuronal excitation by 1-hydroxy-3-amino-pyrrolidone-2
10. Is 1-hydroxy-3-aminopyrrolidone-2 (HA-966) a selective excitatory amino acid antagonist?
11. Microelectrophoretic studies on the depressant action of HA-966 on chemically and synaptically excited neurons in the cat cerebral cortex and cuneate nucleus
12. Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves
13. Low doses of γ-hydroxybutyric acid stimulate the firing rate of dopaminergic neurons in unanesthetized rats
14. Stereoselective R-(+) enantiomer of HA-966 displays anxiolytic effects in rodents
15. B-receptors
16. B-receptor activation alters the firing pattern of dopamine neurons in the rat substantia nigra
17. Specific antagonism of excitant amino acids in the isolated spinal cord of the neonatal rat
18. Glycine reverses antagonism of N-methyl-d-aspartate (NMDA) by 1-hydroxy-3-aminopyrrolidone-2 (HA-966) but not by d-2-amino-5-phophonovalerate (d-AP5) on rat cortical slices
19. HA-966 antagonizes N-methyl-d-aspartate receptors through a selective interaction with the glycine modulatory site
20. Non-competitive N-methyl-d-aspartate antagonists are potent activators of ventral tegmental A10 dopamine neurons
21. MK-801, Phencyclidine (PCP), and PCP-like drugs increase bursting firing in rat A10 dopamine neurons: comparison to competitive NMDA antagonists
22. Selective increase of brain dopamine induced by gamma-hydroxybutyrate
23. The NMDA glycine site antagonist (+)HA-966 selectively regulates conditioned stress-induced metabolic activation of the mesoprefrontal cortical dopamine but not serotonin systems: a behavioral, neuroendocrine, and neurochemical study in the rat
24. Nonlinear relationship between impulse flow and dopamine released by rat midbrain dopaminergic neurons as studied by in vivo electrochemistry
25. Nigral dopamine neurons: intracellular recording and identification with L-dopa injection and histofluorescence
26. Effects of baclofen on nigral dopaminergic cell activity following acute and chronic haloperidol treatment
27. The excitatory amino acid antagonist kynurenate induces pacemaker-like firing of dopamine neurons in rat ventral tegmental area in vivo
28. Competitive antagonists and partial agonists at the glycine modulatory site of the mouse N-methyl-d-aspartate receptor
29. The influence of 1-hydroxy-3-amino-pyrrolidone-2 (HA-966) on dopamine metabolism in the rat corpus striatum
30. 1-Hydroxy-3-amino-pyrrolidone-2 (HA-966). III. Neurochemical aspects
31. Burst firing in dopamine neurons induced by N-methyl-d-aspartate: role of electrogenic sodium pump
32. Effects of frequency and pattern of medial forebrain bundle stimulation on caudate dialysate dopamine and serotonin
33. Effects of zoxazolamine and related centrally acting muscle relaxants on nigrostriatal dopaminergic neurons
34. On central muscle relaxants, strychnine-insensitive glycine receptors and two old drugs: zoxazolamine an HA-966
35. Demonstration of the antimyoclonic effect of 1-hydroxy-3-amino-pyrrolidone-2 (HA-966) using a new animal model
36. (+)-HA-966, a partial agonist at the glycine site coupled to NMDA receptors, blocks formalin-induced pain in mice
37. Stress activation of mesocorticolimbic dopamine neurons: effects of a glycine/NMDA receptor antagonist
38. Pharmacologically induced cessation of burst activity in nigral dopamine neurons: significance for the terminal dopamine efflux
39. B receptors
40. Iontophoretically administered drugs acting at the N-methyl-d-aspartate receptor modulate burst firing in A9 dopamine neurons in the rat
41. Stereoselectivity for the (R)-enantiomer of HA-966 (1-hydroxy-3-aminopyrrolidone-2) at the glycine site of the N-methyl-d-aspartate receptor complex
42. γ-Butyrolactone and γ-hydroxybutyric acid. I. Distribution and metabolism
43. Gamma-hydroxybutyrate: a role in the regulation of central dopaminergic neurons?
44. Electrophysiological properties of mouse dopamine neurons: in vivo and in vitro studies
45. Effects of apamin on the discharge properties of putative dopamine-containing neurons in vitro
46. (±)-1-Hydroxy-3-aminopyrrolidone-2 (HA-966) inhibits the activity of substantia nigra dopamine neurons through a non-N-methyl-d-aspartate receptor-mediated mechanism
47. B receptors
48. The cellular basis of conditional bursting activity in mesencephalic dopamine-containing neurons
49. Intracellular studies of dopamine neurons in vitro: pacemakers modulated by dopamine
50. Enantiomers of HA-966 (3-amino-1-hydroxypyrrolid-2-one) exhibit distinct central nervous system effects: (+)-HA-966 is a selective glycine / N-methyl-d-aspartate receptor antagonist, but (-)-HA-966 is a potent γ-butyrolactone-like sedative
51. Blockade by amino acid antagonists of neuronal excitation mediated by the pyramidal tract
52. Relationship between dopamine release in the rat nucleus accumbens and the discharge activity of dopaminergic neurons during local in vivo application of amino acids in the ventral tegmental area
53. Kynurenate blocks the acute effects of haloperidol on midbrain dopamine neurons recorded in vivo
54. 1-Hydroxy-3-amino-pyrrolidone-2 (HA-966). IV. Clinical aspects
55. Electrical stimulation of the nigrostriatal pathway after HA-966 block of striatal dopamine release
56. Different stereoselectivity of the enantiomers of HA-966 (3-amino-1-hydroxy-2-pyrrolidinone) for neuroprotective and anticonvulsant actions in vivo
57. B antagonist, CGP 35348, antagonizes the effects of baclofen, γ-butyrolactone and HA 966 on rat striatal dopamine synthesis
58. Dopaminergic neurons: inhibition of firing by γ-hydroxybutyrate
59. The variability of central neural activity in a sensory system, and its implications for the central reflection of sensory events
60. The effect of acidic amino acid antagonists on synaptic transmission in the hippocampal formation in vitro